News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
U.S. to Review Safety of Pfizer Inc., Procter & Gamble Cough Medicine Ingredient
May 3, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- U.S. health regulators are concerned about the potential for people to abuse a key ingredient in many cough suppressant medications, calling for a public meeting in September to weigh the issue.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Pfizer
MORE ON THIS TOPIC
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
·
2 min read
·
Tristan Manalac
Opinion
FDA Inspections Should Not Be Source of Stress
January 27, 2026
·
5 min read
·
Greg Walker
Government
Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive
January 23, 2026
·
3 min read
·
Tristan Manalac
Rare diseases
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way
January 23, 2026
·
3 min read
·
Heather McKenzie